Apr 1, 2009
"Best Pharma not Big Pharma" is Merck Serono head Elmar Schnee's business philosophy. He tells Pharm Exec Europe how the Swiss-based company aims to achieve that goal, and points out the current political obstacles.
 |
Mar 18, 2009 By:George Koroneos, Online Content & News Editor
Pharm Exec sits down with Kathryn Metcalfe, Pfizer's new vice president of corporate reputation and policy communications to discuss the new position, the perception of pharma among laypeople, and what needs to be done to boost public opinion of the drug industry.
 |
A new equation to bridge health and wealth Feb 1, 2009 By:Joanna Breitstein
The world is suffering. But just over the horizon is a new access equation that could speed innovative vaccines to where they're needed most.
 |
Jan 16, 2009
Although stem cell research has sparked controversy for years, Osiris Therapeutics has been flying under the radar for a decade with a revolutionary secret.
 |
Dec 11, 2008 By:George Koroneos, Online Content & News Editor
Pharm Exec talks with James Christian, head of security at Novartis, to learn more about what the company is doing to protect its supply chain and stop counterfeiters
 |
Dec 11, 2008 By:Patrick Clinton
Two years ago, an internal Merck survey revealed that its basic research operation was "every flavor of what you don't want." Today the company is in the midst of implementing a new strategy that groups scientists at sites dedicated to particular clinical areas. VP Kathleen Metters explains why - and how.
 |
Dec 1, 2008 By:Ron Feemster
We scrub industry's pipeline to find the drugs that everyone will be talking about in 2009 and beyond
 |
It's been a year since consumer-marketing master Joe Jimenez took over the top spot at Novartis Pharma. How's he faring? Nov 1, 2008
It's been a year since consumer marketing master Joe Jimenez took over the top spot at Novartis Pharma. How's he faring?
 |
|